IE910820A1
(en)
*
|
1990-03-22 |
1991-09-25 |
Sloan Kettering Inst Cancer |
Gp75 as a tumor vaccine for melanoma
|
JPH06509578A
(ja)
*
|
1991-07-26 |
1994-10-27 |
ユニバーシティ・オブ・ロチェスター |
悪性細胞利用による癌治療法
|
US5462871A
(en)
*
|
1992-08-31 |
1995-10-31 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules which encode MAGE derived nonapeptides
|
US5925362A
(en)
*
|
1993-08-11 |
1999-07-20 |
Jenner Technologies |
Method to elicit an antitumor response with human prostate-specific antigen
|
ATE272113T1
(de)
*
|
1994-02-16 |
2004-08-15 |
Crucell Holland Bv |
Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
|
EP0756604A1
(de)
*
|
1994-04-22 |
1997-02-05 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Melanoma antigene
|
US5874560A
(en)
*
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
US8791237B2
(en)
*
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
US7820180B2
(en)
*
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
US20070264279A1
(en)
*
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
US7794729B2
(en)
*
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
US8114414B2
(en)
*
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
US7662396B2
(en)
*
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
US5843648A
(en)
*
|
1995-01-10 |
1998-12-01 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
|
WO1997012220A2
(en)
*
|
1995-09-15 |
1997-04-03 |
Samir Chachoua |
Method for the identification and therapeutic use of disease-associated organisms, elements and forces
|
US7501501B2
(en)
*
|
1995-09-26 |
2009-03-10 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services |
MHC-Class II restricted melanoma antigens and their use in therapeutic methods
|
US6951917B1
(en)
|
1995-09-26 |
2005-10-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
MHC-class II restricted melanoma antigens and their use in therapeutic methods
|
US20040156861A1
(en)
*
|
1996-07-11 |
2004-08-12 |
Figdor Carl Gustav |
Melanoma associated peptide analogues and vaccines against melanoma
|
US6328969B1
(en)
*
|
1996-12-10 |
2001-12-11 |
Sloan-Kettering Institute For Cancer Research |
Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
|
US7556805B2
(en)
*
|
1996-12-10 |
2009-07-07 |
Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center |
Compositions for treatment of melanoma and method of using same
|
US20020155093A1
(en)
*
|
1997-02-18 |
2002-10-24 |
Houghton Alan N. |
Method for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
|
US20100068263A1
(en)
*
|
1997-02-18 |
2010-03-18 |
Sloan-Kettering Institute For Cancer Research |
Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen
|
US8021666B2
(en)
*
|
1997-02-18 |
2011-09-20 |
Sloan-Kettering Institute For Cancer Research |
Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen
|
US20100068216A1
(en)
*
|
1997-02-18 |
2010-03-18 |
Sloan-Kettering Institute For Cancer Research |
Method and Compositions for Stimulation of an Immune Response to gp100 using a Xenogeneic gp100 Antigen
|
US20100068262A1
(en)
*
|
1997-02-18 |
2010-03-18 |
Sloan-Kettering Institute For Cancer Research |
Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen
|
DE19821925A1
(de)
*
|
1998-05-15 |
1999-11-18 |
Roehnisch Tim |
Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
|
JP4932086B2
(ja)
|
1999-04-08 |
2012-05-16 |
インターセル ユーエスエイ、インコーポレイテッド |
経皮的免疫のための乾燥製剤
|
AU2001234616A1
(en)
*
|
2000-01-31 |
2001-08-07 |
Vic Jira |
Vaccine composition, process and methods
|
EP1285272A2
(de)
|
2000-02-08 |
2003-02-26 |
University of British Columbia |
Zusammensetzungen und verfahren zum screenen von therapeutischen agenzien
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
EP1303299B1
(de)
*
|
2000-03-29 |
2010-07-28 |
The Trustees of The University of Pennsylvania |
Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen
|
US6855320B2
(en)
*
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
US7700344B2
(en)
*
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
US8771702B2
(en)
*
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
WO2003018610A2
(en)
|
2001-08-22 |
2003-03-06 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
|
US7176278B2
(en)
*
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
US20070031440A1
(en)
*
|
2001-08-30 |
2007-02-08 |
Prior Christopher P |
Modified transferin-antibody fusion proteins
|
US8129504B2
(en)
|
2001-08-30 |
2012-03-06 |
Biorexis Technology, Inc. |
Oral delivery of modified transferrin fusion proteins
|
BR0212256A
(pt)
*
|
2001-08-30 |
2004-08-31 |
Biorexis Pharmaceutical Corp |
Proteìnas de fusão de transferrina modificadas
|
US20030226155A1
(en)
*
|
2001-08-30 |
2003-12-04 |
Biorexis Pharmaceutical Corporation |
Modified transferrin-antibody fusion proteins
|
ES2347144T3
(es)
*
|
2002-08-30 |
2010-10-26 |
Biorexis Pharmaceutical Corporation |
Proteinas de fusion de la transferrina modificada que comprenden dominos aino o carboxilo de transferrina duplicados.
|
US20060105387A1
(en)
*
|
2002-08-30 |
2006-05-18 |
Prior Christopher P |
Transferrin fusion proteins libraries
|
US20070060512A1
(en)
*
|
2003-03-04 |
2007-03-15 |
Homayoun Sadeghi |
Dipeptidyl-peptidase protected protein
|
US7379700B2
(en)
*
|
2003-05-06 |
2008-05-27 |
Canon Kabushiki Kaisha |
Image reading apparatus with rotatable internal and external guides
|
US8207314B2
(en)
*
|
2003-05-16 |
2012-06-26 |
Sanofi Pasteur Limited |
Tumor antigens for prevention and/or treatment of cancer
|
WO2005021579A2
(en)
*
|
2003-08-28 |
2005-03-10 |
Biorexis Pharmaceutical Corporation |
Epo mimetic peptides and fusion proteins
|
US20060205037A1
(en)
*
|
2003-08-28 |
2006-09-14 |
Homayoun Sadeghi |
Modified transferrin fusion proteins
|
CN101242869B
(zh)
|
2005-09-02 |
2010-05-26 |
Iomai公司 |
经皮递送疫苗和透皮递送药物的装置及其应用
|
WO2008012629A2
(en)
|
2006-07-24 |
2008-01-31 |
Biorexis Pharmaceutical Corporation |
Exendin fusion proteins
|
EP2056849A4
(de)
*
|
2006-08-04 |
2010-09-08 |
Univ Pennsylvania |
Verfahren und zusammensetzungen zur behandlung von ige-vermittelten erkrankungen
|
US8268326B2
(en)
*
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
EP2977456B1
(de)
*
|
2006-08-15 |
2017-10-25 |
The Trustees Of The University Of Pennsylvania |
Zusammensetzungen mit hmw-maa und fragmenten davon zur behandlung von krebs
|
EP2288379A4
(de)
|
2008-05-19 |
2012-08-08 |
Advaxis |
Doppeltes freisetzungssystem für heterologe antigene
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
US20090005320A1
(en)
*
|
2008-09-02 |
2009-01-01 |
Bruce Kneller |
Compositions comprising amino acid bicarbonate and methods of use thereof
|
JP5539411B2
(ja)
|
2009-03-04 |
2014-07-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
血管新生因子を含む組成物およびその使用方法
|
CN102573883A
(zh)
|
2009-06-12 |
2012-07-11 |
疫苗技术公司 |
用于促进细胞-介导的免疫应答的方法和组合物
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
WO2012138377A2
(en)
|
2010-10-01 |
2012-10-11 |
Trustees Of The University Of Pennsylvania |
The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
|
EP2683400A4
(de)
|
2011-03-11 |
2014-09-17 |
Advaxis |
Adjuvanzien auf listerien-basis
|
SG11201405605VA
(en)
|
2012-03-12 |
2014-10-30 |
Advaxis Inc |
SUPPRESSOR CELL FUNCTION INHIBITION FOLLOWING <i>LISTERIA</i> VACCINE TREATMENT
|
WO2014044690A1
(en)
|
2012-09-18 |
2014-03-27 |
Valneva Austria Gmbh |
Improved vaccines
|